This federal contract award is for the procurement of advanced cardiovascular medical devices, including transcatheter aortic valve replacement (TAVR) heart valves, surgical implants, and related technologies. The contract was awarded to Edwards Lifesciences LLC, a for-profit limited liability company and subsidiary of Edwards Lifesciences Corporation, a global leader in medical innovations for structural heart disease and critical care monitoring.
The contract is a $34,000 firm fixed-price purchase order, with an ultimate completion date of October 2, 2025. It was awarded by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network (VISN) 23, to support the VA's healthcare system. The contract does not have a set-aside designation. Edwards Lifesciences LLC is recognized as a self-certified small disadvantaged business and has been awarded multiple Indefinite Delivery Contracts (IDCs) by other VISNs, valued at $4,261,359.80 and $1,870,000, for the procurement of specialized heart valve products and cardiovascular equipment.
Generated 9/3/25, 9:51 AM